Moreover, a chemical compound that inhibits both IGF‐1 and STAT3 signaling has been reported to reduce intestinal tumor burden induced by Apc deletion by affecting several stromal cells (Sanchez‐Lopez et al, 2016). The gene discussed is IGF1; the disease is intestinal neoplasm.